文献速递关节外科

采用新型初次置换假体构建的关节型间隔器在感染性全膝关节置换二期翻修中可能提供持久结果

An articulated spacer made of new primary implants in two-stage exchange for infected total knee arthroplasty may provide durable results.
PubMed 文献 · Bone Joint J · 2020-01-01

本研究纳入47例(48膝)符合感染标准、接受新型初次膝关节假体作为关节型间隔器行二期翻修的患者,至少随访两年,比较保留第一阶段假体组与完成二期翻修组的结局。初始成功率为79%(38/48),二次成功率为91%(44/48膝);两组在感染失败率、活动度及生活质量评估方面无显著差异。

要点

  • 新型初次膝关节假体作为关节型间隔器行二期翻修,初始成功率为79%(38/48膝),二次成功率为91%(44/48膝)。
  • 8膝(16%)因感染控制失败而失败,2例患者(2膝)在第一年内死于非直接相关原因。
  • 保留第一阶段假体的病例与完成二期翻修者在感染失败率、活动度和生活质量上无显著差异。

核心结论

  • 采用新型初次膝关节假体作为关节型间隔器的二期翻修方案可实现充分的感染控制。
  • 在选定病例中,保留第一阶段假体可获得与完成二期翻修手术者相当的结果,感染控制、活动度和生活质量评估无差异。

研究设计与样本

  • 纳入47例患者(48膝),均有感染阳性标准,至少随访两年,采用新型初次假体作为关节型间隔器行二期翻修。
  • 平均随访3.7年(范围2.0至6.5年)。
  • 比较保留第一阶段假体组与完成二期翻修组的结局。

主要发现

  • 8膝(16%)因感染控制失败而直接失败,2例患者(2膝)在第一年内死于非直接相关原因,初始成功率为79%(38/48)。
  • 后续手术后的二次成功率为91%(44/48膝)。
  • 在最初保留的间隔器中,4膝(22%)因持续症状需行二期翻修,1膝(5%)因急性感染需行二期翻修。
  • 保留第一阶段手术者与完成二期手术者在感染失败率、活动度和生活质量评估方面无显著差异。

关键数值与推荐

  • 感染控制率:初始成功率79%(38/48膝),二次成功率91%(44/48膝)。
  • 保留的间隔器中,4膝(22%)因持续症状需二期翻修,1膝(5%)因急性感染需二期翻修。
  • 结局评估包括西安大略和麦克马斯特大学骨关节炎指数、膝关节损伤和骨关节炎结局评分、牛津膝关节评分、12项简短健康调查问卷、加州大学洛杉矶分校活动评分及满意度评分。

临床怎么用

  • 作者方案为对感染性膝关节置换行二期翻修,使用新型初次膝关节假体作为关节型间隔器,可实现充分的感染控制。
  • 作者认为在选定病例中保留第一阶段假体可获得与完成二期翻修相当的感染控制、活动度和生活质量结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Our objective is to describe our early and mid-term results with the use of a new simple primary knee prosthesis as an articulating spacer in planned two-stage management for infected knee arthroplasty. As a second objective, we compared outcomes between the group with a retained first stage and those with a complete two-stage revision. METHODS: We included 47 patients (48 knees) with positive criteria for infection, with a minimum two-year follow-up, in which a two-stage approach with an articulating spacer with new implants was used. Patients with infection control, and a stable and functional knee were allowed to retain the initial first-stage components. Outcomes recorded included: infection control rate, reoperations, final range of motion (ROM), and quality of life assessment (QoL) including Western Ontario and McMaster Universities osteoarthritis index, Knee Injury and Osteoarthritis Outcome Score, Oxford Knee Score, 12-Item Short-Form Health Survey questionnaire, and University of California Los Angeles (UCLA) activity score and satisfaction score. These outcomes were evaluated and compared to additional cohorts of patients with retained first-stage interventions and those with a complete two-stage revision. Mean follow-up was 3.7 years (2.0 to 6.5). RESULTS: Eight knees failed directly related to lack of infection control (16%), and two patients (two knees) died within the first year for causes not directly related, giving an initial success rate of 79% (38/48). Secondary success rate after a subsequent procedure was 91% (44/48 knees). From the initially retained spacers, four knees (22%) required a second-stage revision for continuous symptoms and one (5%) for an acute infection. There were no significant differences regarding the failure rate due to infection, ROM, and QoL assessment between patients with a retained first-stage procedure and those who underwent a second-stage operation. CONCLUSION: Our protocol of two-stage exchange for infected knee arthroplasties with an articulating spacer and using new primary knee implants achieves adequate infection control. Retained first-stage operations achieve comparable results in selected cases, with no difference in infection control, ROM, and QoL assessment in comparison to patients with completed two-stage revision surgery. Cite this article: Bone Joint J 2020;102-B(7):852-860.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Zamora T, Garbuz DS, Greidanus NV, et al. An articulated spacer made of new primary implants in two-stage exchange for infected total knee arthroplasty may provide durable results. Bone Joint J. 2020. PMID: 32600135. doi:10.1302/0301-620X.102B7.BJJ-2019-1443.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。